Nippon Telegraph & Telephone Corp. ADS (NTT) Financials Nov
Nippon Telegraph & Telephone Corp. ADS (NTT) Financials Nov 17, 2014, 4:02 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Nippon Telegraph & Telephone Corp. ADS
Fiscal year is April-March. All values JPY millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 10.18T 10.31T 10.51T 10.7T 10.93T
Cost of Goods Sold (COGS) incl. D&A 6.05T 6.1T 6.29T 6.47T 6.77T
COGS excluding D&A 4.04T 4.13T 4.38T 4.57T 4.89T
Depreciation & Amortization Expense 2.01T 1.96T 1.91T 1.9T 1.88T
Depreciation 1.38T 1.5T 1.43T 1.43T 1.39T
Amortization of Intangibles 630.19B 462.65B 481.04B 473.25B 493.44B
Gross Income 4.13T 4.21T 4.22T 4.23T 4.15T
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 3T 2.99T 2.98T 2.99T 2.93T
Research & Development 278.14B 268.22B 267.85B 269.19B 249.3B
Other SG&A 2.72T 2.72T 2.71T 2.72T 2.68T
Other Operating Expense 0 0 0 0 0
Unusual Expense 8.5B (4.31B) 13.1B 34.28B (52.47B)
EBIT after Unusual Expense (8.5B) 4.31B (13.1B) (34.28B) 52.47B
Non Operating Income/Expense 33.52B (13.63B) 51.46B 33.35B 46.2B
Non-Operating Interest Income 24B 21.6B 19.3B 17.64B 17.63B
Equity in Affiliates (Pretax) - - - - -
Interest Expense 55.15B 55.27B 56.33B 54.34B 47.68B
Gross Interest Expense 55.15B 58.83B 59.91B 58.27B 51.46B
Interest Capitalized - 3.56B 3.59B 3.93B 3.78B
Pretax Income 1.12T 1.18T 1.24T 1.2T 1.29T
Income Tax 447B 475.59B 587.79B 481.23B 486.55B
Income Tax - Current Domestic 494.47B 448.81B 451.22B 461.5B 483.11B
Income Tax - Current Foreign 0 - - - -
Income Tax - Deferred Domestic (47.47B) 26.78B 136.57B 19.73B 3.43B
Income Tax - Deferred Foreign 0 - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 8.79B 1.67B (2.99B) (10.13B) (50.79B)
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 681.86B 701.88B 648.55B 709.74B 756.86B
Minority Interest Expense 189.6B 192.25B 180.85B 185.67B 171.38B
Net Income 492.27B 509.63B 467.7B 524.07B 585.47B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 492.27B 509.63B 467.7B 524.07B 585.47B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 492.27B 509.63B 467.7B 524.07B 585.47B
EPS (Basic) 372.01 385.16 366.67 432.44 509.21
Basic Shares Outstanding 1.32B 1.32B 1.28B 1.21B 1.15B
EPS (Diluted) 372.01 385.16 366.67 432.44 509.21
Diluted Shares Outstanding - 1.32B 1.28B 1.21B 1.15B
EBITDA 3.14T 3.18T 3.15T 3.14T 3.11T
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....
Continue Reading
PCS Wireless Dives Deeper into Japan's Reuse Market Never thought I'd live to see recycling grabbing headlines, but here we are. PCS Wireless just made a bold move in Japan, aiming to turbocharge its reuse game. They've thrown a hat in the ring with ReNet Japan Group Co., Ltd. (TSE: 3556), splashing cash to snatch up a hefty 10.36% of the company's voting rights. This...
Continue Reading
Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...
Continue Reading
Interest Rates Climb, CLO Metrics Hold Firm Buckle up, folks. As interest rates drift higher like a stubborn balloon, investors are scouring the landscape for any sign of a shaky foundation. Well, here's a bit of solace in the storm: Egan-Jones, the credit rating powerhouse, has released their latest musings on the collateralized loan obligation (CLO) market...
Continue Reading
A Dark Day in Jordan It's a gut punch, hearing news of yet another brutal attack targeting the Christian community in Jordan's Karak province. This act of terror isn't just a regional dagger—it cuts deep into the fabric of shared humanity. On Friday, the tranquil air of a sacred gathering was shattered, leaving behind grief and a call to action for those who refuse to...
Continue Reading
Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...
Continue Reading
A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...
Continue Reading
Gildan's Channel Stuffing Allegations If July showers bring August flowers, then what do June allegations bring? A stock nosedive, if you’re Gildan Activewear. Investors woke up June 16, 2026, to a harrowing drop, with shares slipping nearly 19%. It's the kind of gut-punch that makes one wonder if summer vacation is over before it even starts. Jehoshaphat Research...
Continue Reading
AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...
Continue Reading
A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...
Continue Reading
Top 5 Most Recently Viewed Articles
Warren Buffett’s reign over Berkshire Hathaway (NYSE: BRK.A, NYSE: BRK.B) set a benchmark back in the day that still gets traders buzzing. You gotta love the Oracle of Omaha; he’s been schooling investors on the importance of finding those companies with real competitive moats—ya know, businesses that can fend off competition like a fortress. Back then, it was all...
Continue Reading
Valvoline Inc. CFO Transition and Retirement Announcement Valvoline Inc. (NYSE: VVV), known as a leader in preventive automotive maintenance, is navigating a transformative period with the upcoming retirement of its Chief Financial Officer, Mary Meixelsperger. This retirement marks the conclusion of an important chapter as Meixelsperger continues her role until a...
Continue Reading
Tenant Inc. Enhances Self-Storage Management with nodaFi Tenant Inc., a frontrunner in the self-storage technology space, has recently revealed an exciting partnership with nodaFi, focusing on optimizing operations across self-storage facilities. This collaboration introduces a robust integration that aims to improve efficiency and provide real-time insights, ensuring...
Continue Reading
Progress Update on the Android Transaction Dundee Corporation (TSX: DC.A) has provided a significant update on the ongoing sale of Android Industries. Since entering a binding Share Purchase Agreement, the parties involved have made substantial strides in addressing the preconditions needed for the deal to close. Most of these conditions have been fulfilled, yet, key...
Continue Reading
Exciting Developments in Dravet Syndrome Treatment An important collaboration between Biogen Inc. (NASDAQ: BIIB) and Stoke Therapeutics, Inc. (NASDAQ: STOK) has led to new findings regarding zorevunersen, an investigational antisense oligonucleotide. This promising treatment is currently being evaluated as a potential option for those affected by Dravet syndrome, a severe...
Continue Reading